Stocktoria
FILANA THERAPEUTICS, INC. FLNA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-07-14
FILANA THERAPEUTICS, INC. statistics & valuation
Market cap$58.0M
P / B0.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Return on assets | -76.9% | -15.5% | -64.1% | -32.5% | — |
| Return on equity | -122.3% | -16.7% | -70.7% | -33.5% | — |
| Current ratio | 2.23 | 11.62 | 9.13 | 29.91 | 22.06 |
Source: SEC EDGAR filings · CIK 0001069530 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.